"This is not a drill," says Erin Gibbs when talking about 2026 being "the year" for small and mid-cap stocks. She explains what makes the coming year different from past bullish expectations which experienced head fakes. Erin's top picks include Krystal Biotech (KRYS), Exelixis (EXEL), and Neurocrine (NBIX).
Morning Movers
10 Dec 2025
SHARE